SCCM Resource Library-It's All in the Brain: Updates in Pharmacotherapy of Neurocritical Care Patients

It's All in the Brain: Updates in Pharmacotherapy of Neurocritical Care Patients

Video Transcription

Video Summary

The talk highlights significant updates in neurocritical care for 2023, focusing on stroke and hemorrhage management. Key points include optimal blood pressure control after thrombectomy, indicating intensive control worsens outcomes, and recommending a systolic goal of under 180. Early DOAC initiation in patients with atrial fibrillation appears safe with a lower risk of recurrent stroke. For intracerebral hemorrhage, andexanet-alpha improves hemostatic efficacy but raises ischemic stroke risks. Additionally, bundled care with strict hemodynamic and metabolic regulation enhances outcomes in spontaneous ICH. These insights guide treatment approaches for improved patient results.

Asset Caption

Year in Review | Year in Review: Clinical Pharmacy and Pharmacology (Flipped Classroom)

Meta Tag

Content Type Presentation

Membership Level Professional

Membership Level Select

Year 2024

Keywords

neurocritical care

stroke management

hemorrhage management

blood pressure control

DOAC initiation

	Society of Critical Care Medicine 500 Midway Drive Mount Prospect, IL 60056 USA Phone: +1 847 827-6888 Fax: +1 847 439-7226 Email: support@sccm.org	Contact Us About SCCM Newsroom Advertising & Sponsorship DONATE	MySCCM LearnICU Patients & Families Surviving Sepsis Campaign Critical Care Societies Collaborative	GET OUR NEWSLETTER
© Society of Critical Care Medicine. All rights reserved. \| Privacy Statement \| Terms & Conditions The Society of Critical Care Medicine, SCCM, and Critical Care Congress are registered trademarks of the Society of Critical Care Medicine.